<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="17184">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02883179</url>
  </required_header>
  <id_info>
    <org_study_id>LPPT</org_study_id>
    <nct_id>NCT02883179</nct_id>
  </id_info>
  <brief_title>Pain Relief During Repair of Postpartum Perineal Tears</brief_title>
  <acronym>LPPT</acronym>
  <official_title>Topical Lidocaine-prilocaine Cream Versus Lidocaine Infiltration for Pain Relief During Repair of Postpartum Perineal Tears: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of our study is to compare the analgesic effect of topical application of
      lidocaine-prilocaine cream and lidocaine infiltration during repair of postpartum perineal
      tears.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean pain score during suture of perineal tears</measure>
    <time_frame>30 minutes</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>Improving Quality of Life</condition>
  <arm_group>
    <arm_group_label>lidocaine injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>5 mL of 2% lidocaine anhydrous solution (Depocaine) will be injected slowly along the lines of the edges of the perineal tears after delivery, with frequent aspirations to avoid intravascular injection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lidocaine-prilocaine cream</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5-g dose of Lidocaine-prilocaine cream will be applied to the intact tissue around each tear for 5 minutes before suturing</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lidocaine injection</intervention_name>
    <description>anhydrous solution</description>
    <arm_group_label>lidocaine injection</arm_group_label>
    <other_name>depocaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lidocaine-prilocaine cream</intervention_name>
    <description>topical cream</description>
    <arm_group_label>lidocaine-prilocaine cream</arm_group_label>
    <other_name>pridocaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Gestational age &gt; 37 weeks

          2. Uncomplicated pregnancy

          3. Single vertex fetus

          4. Normal vaginal delivery

          5. Women who will accept to participate in the study

        Exclusion Criteria:

          1. Women received epidural analgesia

          2. Women required episiotomy

          3. Women with intact perineum

          4. Operative vaginal delivery

          5. Allergy to the used drugs
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ahmed Abbas, MD</last_name>
    <phone>00201003385183</phone>
    <email>bmr90@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ahmed Abbas</name>
      <address>
        <city>Assiut</city>
        <state>Cairo</state>
        <zip>002</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ahmed abbas, MD</last_name>
      <email>bmr90@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>ahmed abbas</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 1, 2017</lastchanged_date>
  <firstreceived_date>August 22, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ahmed Mohamed Abbas</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Prilocaine</mesh_term>
    <mesh_term>EMLA</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
